Phase I Study of Immunization with Dendritic Cells Modified with Fowlpox Encoding Carcinoembryonic Antigen and Costimulatory MoleculesMichael A. Morse, H. Kim Lyerly, Jeffrey Schlom et al.|Clinical Cancer Research|2005Cited by 129
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2Michael A. Morse, Timothy M. Clay, Gayathri R. Devi et al.|Journal of Translational Medicine|2007Cited by 45
Phase I study of immunization with dendritic cells (DC) modified with recombinant fowlpox encoding carcinoembryonic antigen (CEA) and the triad of costimulatory molecules CD54, CD58, and CD80 (rF-CEA(6D)-TRICOM) in patients with advanced malignanciesMichael A. Morse, H. Kim Lyerly, Timothy Clay et al.|Journal of Clinical Oncology|2004Cited by 13
Phase I study of immunization with dendritic cells (DC) modified with recombinant fowlpox encoding carcinoembryonic antigen (CEA) and the triad of costimulatory molecules CD54, CD58, and CD80 (rF-CEA(6D)-TRICOM) in patients with advanced malignanciesMichael Morse, H. Kim Lyerly, Timothy Clay et al.|Journal of Clinical Oncology|2004Cited by 4